Has agricultural intensification impacted maize root traits and rhizosphere interactions related to organic N acquisition?

Has agricultural intensification impacted maize root traits and rhizosphere interactions related to organic N acquisition?

plant-microbe interactions in the rhizosphere influence the level of mineralization of organic matter and nutrient cycling that is essential for sustainable agricultural productivity. intensification of agriculture, particularly the introduction of synthetic fertilizer in the United States, changed the abundance and dominant forms of nitrogen (N), essential plant nutrients, potentially impose selection pressure on the properties of plants and plant-microbe interactions that regulate N cycling and acquisitions.

We hypothesize that the adaptation of corn to N fertilization synthetic functional properties and altered root rhizosphere microbial nutrient cycles, reducing the ability of corn to obtain N from organic sources. Six inbreds released pre-fertilizer (1936, 1939, 1942) or post-fertilizer (1984, 1994, 2015) were grown in rhizoboxes 15N-labeled blots containing clover / vetch residue. multivariate approach does not identify the characteristics of a strong and consistent architecture predictable rhizosphere processes, although the morphological plasticity root metrics related to carbon-and N-cycling enzyme activity.

the characteristics of the root, the activities of potential extracellular enzymes (BG, LAP, NAG, urease), the abundance of N-cycling genes (Amoa, narG, nirK, NIR, nosZ) and the absorption of organic N did not differ between the era of the release despite substantial variation among genotypes and replications. Thus, agricultural intensification does not appear to have impaired N cycling and acquisition from organic sources by modern corn and its rhizobiome. Increased mechanistic understanding of rhizosphere processes and their response to selective pressures would contribute greatly to the rhizosphere engineering for sustainable agriculture.


double staining protocol using most popular immunoperoxidase technique can increase the difficulty. Both regular detection system may be cross-talk, when the primary antibodies derived from animals closely related phylogenetically. Color shift polymer 3,3′-diaminobenzidine (DAB) may occur during the second development, which resulted in a poor distinction between the two types of deposits.

A post-DAB technique, intensification-silver-gold sulfide, fine tuned to eliminate these difficulties, that may be very suitable for the cell nucleus and perikarya colocalization of the same cells. The revised method was examined in combination with the other steps subsequent immunoperoxidase or fluorochrome-tagged reagents. Nuclear Antigen (BrdU, c-Fos, and Prox-1) was first visualized with DAB polymer, which is then treated with SSGI, rotating black deposit.

 Has agricultural intensification impacted maize root traits and rhizosphere interactions related to organic N acquisition?
Has agricultural intensification impacted maize root traits and rhizosphere interactions related to organic N acquisition?

Present and Future of de-intensification Strategies in the Treatment of Oropharyngeal Carcinoma

Purpose of review: The treatment of patients with squamous cell carcinoma of the oropharynx (OPSCC) is still controversial. Positive HPV is widely accepted as a favorable prognostic factor, and HPV + OPSCC regarded as different pathological entities with NCCN guidelines are dedicated and probably deserved more personalized treatment strategies.

The possibility to reduce invasive surgical and acute and late toxicity of radiotherapy / chemotherapy has led to a new concept of treatment of de-escalation strategy. In particular, some de-intensive approaches have been investigated with the aim of giving the patient a less toxic treatments, while maintaining comparable results in terms of disease control and survival.

IgD Heavy Chain Antibody

V7860-100UG 100 ug
EUR 424.15
Description: Immunoglobulins are four-chain, Y-shaped, monomeric structures comprised of two identical heavy chains and two identical light chains held together through interchain disulfide bonds. The chains form two domains, the Fab (antigen binding) fragment and the Fc (constant) fragment. Immunoglobulin D (IgD) exists as a monomer with light chains. It plays a biological role as a transmembrane receptor molecule, co-expressed with IgM on the surface of mature/naive B cells. In particular, it is found on spleen B cell surfaces. Compared to IgM, IgD exists in much lower numbers and is not expressed on immature B cells. IgD surface expression on B cells is regulated in part by IL-27. In mice, the inhibition of this immunoglobulin isotype does not cause a significant change to the immune system.

IgD Heavy Chain Antibody

V7860-20UG 20 ug
EUR 186.15
Description: Immunoglobulins are four-chain, Y-shaped, monomeric structures comprised of two identical heavy chains and two identical light chains held together through interchain disulfide bonds. The chains form two domains, the Fab (antigen binding) fragment and the Fc (constant) fragment. Immunoglobulin D (IgD) exists as a monomer with light chains. It plays a biological role as a transmembrane receptor molecule, co-expressed with IgM on the surface of mature/naive B cells. In particular, it is found on spleen B cell surfaces. Compared to IgM, IgD exists in much lower numbers and is not expressed on immature B cells. IgD surface expression on B cells is regulated in part by IL-27. In mice, the inhibition of this immunoglobulin isotype does not cause a significant change to the immune system.

IgD Heavy Chain Antibody

V7860SAF-100UG 100 ug
EUR 424.15
Description: Immunoglobulins are four-chain, Y-shaped, monomeric structures comprised of two identical heavy chains and two identical light chains held together through interchain disulfide bonds. The chains form two domains, the Fab (antigen binding) fragment and the Fc (constant) fragment. Immunoglobulin D (IgD) exists as a monomer with light chains. It plays a biological role as a transmembrane receptor molecule, co-expressed with IgM on the surface of mature/naive B cells. In particular, it is found on spleen B cell surfaces. Compared to IgM, IgD exists in much lower numbers and is not expressed on immature B cells. IgD surface expression on B cells is regulated in part by IL-27. In mice, the inhibition of this immunoglobulin isotype does not cause a significant change to the immune system.

IgD Heavy Chain Antibody (FITC)

GWB-3D8893 0.5 mg Ask for price

IgD Heavy Chain Antibody (Biotin)

GWB-Q00098 0.5 mg Ask for price

Rat Anti Mouse Igd Heavy Chain Monoclonal Antibody

CABT-54648RM 0.25 mg
EUR 651.6

Rat anti-Mouse IgD Heavy Chain Antibody

abx401374-025mg 0.25 mg
EUR 678

Rat IgD (heavy chain) mouse monoclonal antibody, clone MARD-3, Biotin

SM1028B 500 µg Ask for price

Rat IgD (heavy chain) mouse monoclonal antibody, clone MARD-3, Purified

SM1028P 250 µg Ask for price

Human IgD (heavy chain) goat polyclonal antibody, FITC

AP05391FC-N 1 mg Ask for price

Goat F(ab')2 anti-Human IgD Heavy Chain Antibody

abx401504-05mg 0.5 mg
EUR 477.6

Human IgD (heavy chain) goat polyclonal antibody, Purified

AP05391PU-N 1 mg Ask for price

Mouse IgD (Delta heavy chain) rat monoclonal antibody, clone 11-26, PE

AM08012RP-S 100 µg Ask for price

Mouse IgD (Delta heavy chain) rat monoclonal antibody, clone 11-26c, PE

AM08012RP-N 200 µg Ask for price

Mouse IgD (Delta heavy chain) rat monoclonal antibody, clone 11-26, FITC

AM08012FC-N 500 µg Ask for price

Mouse IgD (Delta heavy chain) rat monoclonal antibody, clone 11-26, Biotin

AM08012BT-N 500 µg Ask for price

Immunoglobulin D Heavy Chain (IgD) Rat -FITC, Antibody

GWB-B9F7C8 1 mg Ask for price

Goat F(ab')2 anti-Human IgD Heavy Chain Antibody (FITC)

abx401506-05mg 0.5 mg
EUR 526.8

Mouse IgD (Delta heavy chain) rat monoclonal antibody, clone 11-26, Purified

AM08012PU-N 500 µg Ask for price

Goat F(ab')2 anti-Human IgD Heavy Chain Antibody (Biotin)

abx401505-05mg 0.5 mg
EUR 560.4

Mouse IgD (Delta heavy chain) rat monoclonal antibody, clone 11-26, Low Endotoxin

AM08012LE-N 500 µg Ask for price

Mouse IgM Heavy Chain Antibody

GWB-3BB6AB 1 mg Ask for price

Mouse IgG Heavy Chain Antibody

GWB-849777 0.25 mg Ask for price

Mouse IgA Heavy Chain Antibody

GWB-71AB32 0.25 mg Ask for price

Mouse IgE Heavy Chain Antibody

GWB-7477C0 0.25 mg Ask for price

Mouse IgM Heavy Chain Antibody

GWB-D3B410 0.25 mg Ask for price

Mouse IgG3 Heavy Chain Antibody

GWB-49A4C2 0.25 mg Ask for price

Mouse IgG1 Heavy Chain Antibody

GWB-E46E30 0.25 mg Ask for price

Mouse IgG2b Heavy Chain Antibody

GWB-55C5A0 0.25 mg Ask for price

Mouse IgG2a Heavy Chain Antibody

GWB-8586F4 1 mg Ask for price

Mouse IgG2a Heavy Chain Antibody

GWB-CA8FD2 0.25 mg Ask for price

Mouse Ige Heavy Chain Antibody (HRP)

GWB-8E62CA 0.5 mg Ask for price

Mouse Igg1 Heavy Chain Antibody (HRP)

GWB-1BCE9A 0.5 mg Ask for price

Mouse Ige Heavy Chain Antibody (FITC)

GWB-843D77 0.5 mg Ask for price

Mouse Igm Heavy Chain Antibody (FITC)

GWB-897872 0.5 mg Ask for price

Mouse Igg2A Heavy Chain Antibody (HRP)

GWB-51FBF8 0.5 mg Ask for price

Mouse Igg1 Heavy Chain Antibody (FITC)

GWB-852542 0.5 mg Ask for price

Mouse Igg2A Heavy Chain Antibody (HRP)

GWB-B64A94 0.5 mg Ask for price

Mouse Ige Heavy Chain Antibody (Biotin)

GWB-324BB6 0.5 mg Ask for price

Mouse Igg2A Heavy Chain Antibody (FITC)

GWB-97A1CE 0.5 mg Ask for price

Mouse Igg2B Heavy Chain Antibody (FITC)

GWB-E1E7DF 0.5 mg Ask for price

Mouse Igg Heavy Chain Antibody (Biotin)

GWB-E21C4D 0.5 mg Ask for price

Mouse Igm Heavy Chain Antibody (Biotin)

GWB-E661ED 0.5 mg Ask for price

Mouse Igg2A Heavy Chain Antibody (FITC)

GWB-E83A94 0.5 mg Ask for price

Mouse Igg3 Heavy Chain Antibody (Biotin)

GWB-98CD10 0.5 mg Ask for price

Mouse Igg1 Heavy Chain Antibody (Biotin)

GWB-E219B8 0.5 mg Ask for price

Mouse Igg2A Heavy Chain Antibody (Biotin)

GWB-601D96 0.5 mg Ask for price

Mouse Igg2B Heavy Chain Antibody (Biotin)

GWB-E729B9 0.5 mg Ask for price

Mouse Igg2A Heavy Chain Antibody (Biotin)

GWB-EE32AF 0.5 mg Ask for price

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC802730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF680 conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC802730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF680 conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC812730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF680R conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC812730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF680R conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC432730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF543 conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC432730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF543 conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC052730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF405M conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC052730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF405M conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC552730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF555 conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC552730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF555 conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC702730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF770 conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC702730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF770 conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC612730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF660R conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNC612730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF660R conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNCH2730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNCH2730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNCP2730-250 250uL
EUR 472.8
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), PerCP conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNCR2730-250 250uL
EUR 472.8
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), RPE conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNCA2730-250 250uL
EUR 472.8
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), APC conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNCAP2730-100 100uL
EUR 279.6
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNCAP2730-500 500uL
EUR 654
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R) Antibody

BNUB2730-50 50uL
EUR 486
Description: Primary antibody against IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), 1mg/mL

Mouse anti-Rat IgM Heavy Chain Antibody

abx401299-025mg 0.25 mg
EUR 678

Mouse anti-Rat IgA Heavy Chain Antibody

abx401312-025mg 0.25 mg
EUR 678

Mouse anti-Rat IgG1 Heavy Chain Antibody

abx401319-025mg 0.25 mg
EUR 678

Mouse anti-Duck IgY Heavy Chain Antibody

abx401346-025mg 0.25 mg
EUR 710.4

Mouse anti-Rat IgG2b Heavy Chain Antibody

abx401288-05mg 0.5 mg
EUR 794.4

Mouse anti-Rat IgG2c Heavy Chain Antibody

abx401291-05mg 0.5 mg
EUR 794.4

Mouse anti-Rat IgG2b Heavy Chain Antibody

abx401323-025mg 0.25 mg
EUR 678

Mouse anti-Rat IgG2a Heavy Chain Antibody

abx401351-025mg 0.25 mg
EUR 678

Mouse anti-Human IgA Heavy Chain Antibody

abx401376-02mg 0.2 mg
EUR 678

Mouse anti-Duck IgA1 Heavy Chain Antibody

abx401387-025mg 0.25 mg
EUR 710.4

Mouse anti-Duck IgA2 Heavy Chain Antibody

abx401388-025mg 0.25 mg
EUR 710.4

Mouse anti-Quail IgY Heavy Chain Antibody

abx401389-025mg 0.25 mg
EUR 710.4

Mouse Anti-Human IgA Heavy Chain Antibody

abx401376-100g 100 µg
EUR 450

Mouse Anti-Duck IgA1 Heavy Chain Antibody

abx401387-100g 100 µg
EUR 475

Mouse Anti-Duck IgA2 Heavy Chain Antibody

abx401388-200g 200 µg Ask for price

Mouse Anti-Duck IgA2 Heavy Chain Antibody

abx401388-25g 25 µg
EUR 475

IgG Antibody (heavy chain) (mouse adsorbed)

GWB-Q00100 0.5 mg Ask for price

Myosin Heavy Chain Mouse Monoclonal Antibody

38013 100ul
EUR 319

Myosin Heavy Chain Mouse Monoclonal Antibody

38013-100ul 100ul
EUR 302.4

Myosin Heavy Chain Mouse Monoclonal Antibody

38013-50ul 50ul
EUR 224.4

Myosin Heavy Chain Mouse Monoclonal Antibody

E038013 100μg/100μl
EUR 255
Description: Available in various conjugation types.

Myosin Heavy Chain Mouse Monoclonal Antibody

E12-081 100μg/100μl
EUR 255
Description: Available in various conjugation types.

Myosin Heavy Chain Mouse Monoclonal Antibody

EM1058-100ul 100ul
EUR 124
Description: A Mouse Monoclonal antibody against Myosin Heavy Chain from Human/ Mouse/ Rat/ Fruit Fly/ Nematode. This antibody is tested and validated for IHC, IF

Myosin Heavy Chain Mouse Monoclonal Antibody

EM1058-50ul 50ul
EUR 74
Description: A Mouse Monoclonal antibody against Myosin Heavy Chain from Human/ Mouse/ Rat/ Fruit Fly/ Nematode. This antibody is tested and validated for IHC, IF

Mouse anti-Rat IgM Heavy Chain Antibody (HRP)

abx401307-05mg 0.5 mg
EUR 1028.4

Mouse anti-Rat IgM Heavy Chain Antibody (FITC)

abx401306-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgA Heavy Chain Antibody (FITC)

abx401314-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgG1 Heavy Chain Antibody (HRP)

abx401322-05mg 0.5 mg
EUR 1045.2

Mouse anti-Rat IgG1 Heavy Chain Antibody (FITC)

abx401321-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgG2a Heavy Chain Antibody (HRP)

abx401354-05mg 0.5 mg
EUR 1045.2

Mouse anti-Rat IgG2b Heavy Chain Antibody (FITC)

abx401290-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgG2c Heavy Chain Antibody (FITC)

abx401292-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgM Heavy Chain Antibody (Biotin)

abx401305-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgA Heavy Chain Antibody (Biotin)

abx401313-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgG2a Heavy Chain Antibody (FITC)

abx401353-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgG1 Heavy Chain Antibody (Biotin)

abx401320-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgG2b Heavy Chain Antibody (Biotin)

abx401289-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgG2b Heavy Chain Antibody (Biotin)

abx401324-05mg 0.5 mg
EUR 861.6

Mouse anti-Rat IgG2a Heavy Chain Antibody (Biotin)

abx401352-05mg 0.5 mg
EUR 861.6

Mouse IgM Antibody (heavy chain) (human adsorbed)

GWB-Q00109 0.5 mg Ask for price

Mouse anti IgM (Heavy Chain) Monoclonal Antibody

TA354338 100 µg Ask for price

IgG Heavy Chain Antibody

GWB-Q00053 1 mg Ask for price

IgG Heavy Chain Antibody

GWB-Q00099 0.5 mg Ask for price

IgA Heavy Chain Antibody

GWB-B4AF50 0.2 mg Ask for price

IgG Heavy Chain Antibody

R20163-100UG 100ug
EUR 347.65
Description: This recombinant Mouse IgG antibody reacts to the Fc region of all subclasses of mouse IgG. No cross reactivity with mouse IgM, IgA, IgE, human/rat IgG. It may cross react to goat IgG.

IgG Heavy Chain Antibody

R20163BTN-50UG 50ug
EUR 347.65
Description: This recombinant Mouse IgG antibody reacts to the Fc region of all subclasses of mouse IgG. No cross reactivity with mouse IgM, IgA, IgE, human IgG, and rat IgG. It may cross react to goat IgG.

IgG Heavy Chain Antibody

R20163SAF-250UG 250ug
EUR 832.15
Description: This recombinant Mouse IgG antibody reacts to the Fc region of all subclasses of mouse IgG. No cross reactivity with mouse IgM, IgA, IgE, human/rat IgG. It may cross react to goat IgG.

IgA Heavy Chain Antibody

R20169-100UG 100ug
EUR 347.65
Description: This recombinant Mouse IgA antibody specifically reacts to mIgA. No cross reactivity with IgG1, IgG2a, IgG2b, IgG2c, IgG3, IgM, IgE, or human IgA.

IgA Heavy Chain Antibody

R20169BTN-50UG 50ug
EUR 347.65
Description: This recombinant Mouse IgA antibody specifically reacts to mouse IgA. No cross reactivity with mouse IgG1, IgG2a, IgG2b, IgG2c, IgG3, IgM, IgE, or human IgA.

IgA Heavy Chain Antibody

R20169SAF-250UG 250ug
EUR 832.15
Description: This recombinant Mouse IgA antibody specifically reacts to mIgA. No cross reactivity with IgG1, IgG2a, IgG2b, IgG2c, IgG3, IgM, IgE, or human IgA.

IgM Heavy Chain Antibody

R20170-100UG 100ug
EUR 347.65
Description: This recombinant Mouse IgM antibody reacts to mIgM. No cross reactivity with IgG1, IgG2a, IgG2b, IgG3, IgA, IgE, human/rat/goat IgG.

IgM Heavy Chain Antibody

R20170BTN-50UG 50ug
EUR 347.65
Description: This recombinant Mouse IgM antibody reacts to mouse IgM. No cross reactivity with mouse IgG1, IgG2a, IgG2b, IgG3, IgA, IgE, human IgG, rat IgG, or goat IgG.

IgM Heavy Chain Antibody

R20170SAF-250UG 250ug
EUR 832.15
Description: This recombinant Mouse IgM antibody reacts to mIgM. No cross reactivity with IgG1, IgG2a, IgG2b, IgG3, IgA, IgE, human/rat/goat IgG.

IgG Heavy Chain Antibody

R20176-100UG 100ug
EUR 347.65
Description: This recombinant Mouse IgG antibody reacts to Mouse IgG, including IgG1, IgG2a, IgG2b, and IgG3. No cross reactivity with IgM, IgA, IgE or human/rat/rabbit IgG.

IgG Heavy Chain Antibody

R20176BTN-50UG 50ug
EUR 339.15
Description: This recombinant Mouse IgG antibody reacts to Mouse IgG, including IgG1, IgG2a, IgG2b, and IgG3. No cross reactivity with IgM, IgA, IgE, human IgG, rat IgG, or rabbit IgG.

IgG Heavy Chain Antibody

R20176SAF-250UG 250ug
EUR 832.15
Description: This recombinant Mouse IgG antibody reacts to Mouse IgG, including IgG1, IgG2a, IgG2b, and IgG3. No cross reactivity with IgM, IgA, IgE or human/rat/rabbit IgG.

IgG Heavy Chain Antibody

R20177-100UG 100ug
EUR 347.65
Description: This recombinant Human IgG antibody reacts to the Fc region of all gamma heavy chains of human immunoglobulins, including G1, G2, G3, and G4. No cross reactivity with other human heavy chains or mouse/rat/goat IgG.

IgG Heavy Chain Antibody

R20177BTN-50UG 50ug
EUR 347.65
Description: This recombinant Human IgG antibody reacts to the Fc region of all gamma heavy chains of human immunoglobulins, including G1, G2, G3, and G4. No cross reactivity with other human heavy chains, mouse IgG, rat IgG or goat IgG.

IgG Heavy Chain Antibody

R20177SAF-250UG 250ug
EUR 832.15
Description: This recombinant Human IgG antibody reacts to the Fc region of all gamma heavy chains of human immunoglobulins, including G1, G2, G3, and G4. No cross reactivity with other human heavy chains or mouse/rat/goat IgG.

IgM Heavy Chain Antibody

R20181-100UG 100ug
EUR 347.65
Description: This recombinant Human IgM antibody reacts to the heavy chain of human IgM. No cross reactivity with human IgG, IgA, IgD, or IgE.

IgM Heavy Chain Antibody

R20181BTN-50UG 50ug
EUR 347.65
Description: This recombinant Human IgM antibody reacts to the heavy chain of human IgM. No cross reactivity with human IgG, IgA, IgD, or IgE.

IgM Heavy Chain Antibody

R20181SAF-250UG 250ug
EUR 832.15
Description: This recombinant Human IgM antibody reacts to the heavy chain of human IgM. No cross reactivity with human IgG, IgA, IgD, or IgE.

IgA Heavy Chain Antibody

R20182-100UG 100ug
EUR 347.65
Description: This recombinant Human IgA antibody reacts to human IgA, including both IgA1 and IgA2. No cross reactivity with human IgG, IgM, IgD, or IgE.

IgA Heavy Chain Antibody

R20182BTN-50UG 50ug
EUR 347.65
Description: This recombinant Human IgA antibody reacts to human IgA, including both IgA1 and IgA2. No cross reactivity with human IgG, IgM, IgD, or IgE.

IgG Heavy Chain Antibody

RQ4980 100ul
EUR 356.15
Description: Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. [UniProt]

IgM Heavy Chain Antibody

RQ5073 100ul
EUR 356.15
Description: IgM antibodies play an important role in primary defense mechanisms. They have been shown to be involved in early recognition of external invaders like bacteria and viruses, cellular waste and modified self, as well as in recognition and elimination of precancerous and cancerous lesions. [UniProt]

IgA Heavy Chain Antibody

RQ5074 100ul
EUR 356.15
Description: Immunoglobulin A (IgA, also referred to as sIgA in its secretory form) is an antibody that plays a crucial role in the immune function of mucous membranes. [Wiki]

IgG Heavy Chain Antibody

V9028-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 75kDa, identified as gamma heavy chain of human immunoglobulins. It does not cross-react with IgA, IgM, IgE, or IgD, heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This mAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgG Heavy Chain Antibody

V9028-20UG 20 ug
EUR 186.15
Description: Recognizes a protein of 75kDa, identified as gamma heavy chain of human immunoglobulins. It does not cross-react with IgA, IgM, IgE, or IgD, heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This mAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgG Heavy Chain Antibody

V9028IHC-7ML 7 ml
EUR 424.15
Description: Recognizes a protein of 75kDa, identified as gamma heavy chain of human immunoglobulins. It does not cross-react with IgA, IgM, IgE, or IgD, heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This mAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgG Heavy Chain Antibody

V9028SAF-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 75kDa, identified as gamma heavy chain of human immunoglobulins. It does not cross-react with IgA, IgM, IgE, or IgD, heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This mAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V9029-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This mAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V9029-20UG 20 ug
EUR 186.15
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This mAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V9029IHC-7ML 7 ml
EUR 424.15
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This mAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V9029SAF-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This mAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgA Heavy Chain Antibody

V7859-100UG 100 ug
EUR 349.3
Description: This MAb is specific to heavy chain of IgA and shows minimal cross-reaction with heavy chains of other immunoglobulins. It is reactive with all subclasses of Alpha heavy chain. Immunoglobulins are four-chain, Y-shaped, monomeric structures comprised of two identical heavy chains and two identical light chains held together through inter-chain disulfide bonds. The chains form two domains, the Fab (antigen binding) fragment and the Fc (constant) fragment. Immunoglobulin A (IgA) is the main protein of the mucosal immune system. It is generated by B-cells in gut-associated lymphoid tissues. Daily production of IgA exceeds that of any of the other immunoglobulins.IgA exists mainly in dimers but can also exist as polymers or as monomers. Dimers and polymers contain a joining (J) chain that can be bound by the polymeric immunoglobulin receptor (pIgR) for transportation of the molecule to mucosal surfaces. The most common feature of plasmacytomas, and certain non-Hodgkins lymphomas is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgA Heavy Chain Antibody

V7859-20UG 20 ug
EUR 153.3
Description: This MAb is specific to heavy chain of IgA and shows minimal cross-reaction with heavy chains of other immunoglobulins. It is reactive with all subclasses of Alpha heavy chain. Immunoglobulins are four-chain, Y-shaped, monomeric structures comprised of two identical heavy chains and two identical light chains held together through inter-chain disulfide bonds. The chains form two domains, the Fab (antigen binding) fragment and the Fc (constant) fragment. Immunoglobulin A (IgA) is the main protein of the mucosal immune system. It is generated by B-cells in gut-associated lymphoid tissues. Daily production of IgA exceeds that of any of the other immunoglobulins.IgA exists mainly in dimers but can also exist as polymers or as monomers. Dimers and polymers contain a joining (J) chain that can be bound by the polymeric immunoglobulin receptor (pIgR) for transportation of the molecule to mucosal surfaces. The most common feature of plasmacytomas, and certain non-Hodgkins lymphomas is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgA Heavy Chain Antibody

V7859SAF-100UG 100 ug
EUR 349.3
Description: This MAb is specific to heavy chain of IgA and shows minimal cross-reaction with heavy chains of other immunoglobulins. It is reactive with all subclasses of Alpha heavy chain. Immunoglobulins are four-chain, Y-shaped, monomeric structures comprised of two identical heavy chains and two identical light chains held together through inter-chain disulfide bonds. The chains form two domains, the Fab (antigen binding) fragment and the Fc (constant) fragment. Immunoglobulin A (IgA) is the main protein of the mucosal immune system. It is generated by B-cells in gut-associated lymphoid tissues. Daily production of IgA exceeds that of any of the other immunoglobulins.IgA exists mainly in dimers but can also exist as polymers or as monomers. Dimers and polymers contain a joining (J) chain that can be bound by the polymeric immunoglobulin receptor (pIgR) for transportation of the molecule to mucosal surfaces. The most common feature of plasmacytomas, and certain non-Hodgkins lymphomas is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7862-100UG 100 ug
EUR 349.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin s lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7862-20UG 20 ug
EUR 153.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin s lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7862SAF-100UG 100 ug
EUR 349.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin s lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7866-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7866-20UG 20 ug
EUR 186.15
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7866SAF-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7868-100UG 100 ug
EUR 349.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7868-20UG 20 ug
EUR 153.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7868SAF-100UG 100 ug
EUR 349.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7872-100UG 100 ug
EUR 349.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7872-20UG 20 ug
EUR 153.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V7872SAF-100UG 100 ug
EUR 349.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V8005-100UG 100 ug
EUR 349.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin s lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

IgM Heavy Chain Antibody

V8005-20UG 20 ug
EUR 153.3
Description: Recognizes a protein of 75kDa, identified as mu heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), gamma (IgG), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. Monomeric IgM is expressed as a membrane bound antibody on the surface of B cells and as a pentamer when secreted by plasma cells. IgM antibody is prominent in early immune responses to most antigens. Aberrant levels are associated with immune deficiency states, hereditary deficiencies, myeloma, Waldenstrom's macroglobulinemia, chronic infection and hepatocellular disease. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin s lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

The purpose of this review was to systematically describe the status of research in the de-intensification strategy of surgical and non-surgical in the OPSCC treatment.

Leave A Comment